Central nervous system metastases from diffuse malignant pleural mesothelioma are rare. Here we describe a patient without known asbestos exposure who presented with chest pain, increasing shortness of breath and persistent headache. Evaluation found biphasic malignant mesothelioma of the right hemithorax and a single brain metastasis confirmed by computed tomography. This represents only the second case of a patient with pleural mesothelioma presenting with symptomatic central nervous system metastases.
MossmanB.T., GeeJ.B.L.: Asbestos related diseases. N Engl J Med, 320: 1721–1730, 1989.
2.
HuncharekM., MuscatJ.: Metastases in diffuse pleural mesothelioma: influence of histological type. Thorax, 42: 897–898, 1987.
3.
AntmanK.: Natural history and epidemiology of malignant mesothelioma. Chest, 103(Suppl): 373S–376S, 1993.
4.
KayeJ.A., WangA.M., JoachimC.L., SeltzerS.E., CibasE., SkarinA., AntmanK.H.: Malignant mesothelioma with brain metastases. Am J Med, 80: 95–97, 1986.
5.
SridharK.S., HusseinA.M., GanjeiP., ThurerR.J., RaskinN., BeattieE.J.: Brain metastases in malignant pleural mesothelioma: case report and review of the literature. Am J Clin Oncol, 12: 222–228, 1989.
6.
HuncharekM., MuscatJ.: Cerebral metastases in pleural mesothelioma. Am J Clin Oncol, 13: 180–181, 1990.
ColleoniM., LiessiG., AvventiC., PancheriF., SgarbossaG., VicarioG., ManenteP.: Response to chemotherapy of brain metastases from malignant pleural mesothelioma. Tumori, 82: 456–458, 1996.
12.
McNaughtonW.M., BroughtonM.E., TonerG.C., SchwarzM.A.: Presentation of malignant pleural mesothelioma with cerebral metastases. J R Soc Med, 83: 466–467, 1990.
13.
NielsenC., HansenI.M.: Sarcomatous mesothelioma of the pleura with cerebral metastases. Med J Aust, 153: 625–626, 1990.
14.
WronskiM., BurtM.: Cerebral metastases in pleural mesothelioma: case report and review of the literature. J Neuro-Oncology, 17: 21–26, 1993.
15.
MuskA.W., DolinP.J., ArmstrongB.K., FordJ.M., DeKlerkN.H., HobbsM.S.: The incidence of malignant mesothelioma in Australia 1947-1980. Med J Aust, 150: 242–246, 1989.
16.
PetoJ., HodgsonJ.T., MathewsF.F., JonesJ.R.: Continuing increase in mesothelioma mortality in Britain. Lancet, 1: 535–539, 1995.
17.
HuncharekM.: Changing risk groups for malignant mesothelioma. Cancer, 69: 2704–2711, 1992.
18.
HuncharekM.: Exporting asbestos: disease and policy in the developing world. J Public Health Policy, 14: 51–65, 1993.
SugarbakerD., FloresR., JaklitschM., RichardsW.G., StraussG.M., CorsonJ.M., DeCampM.M., SwansonS.J., BuenoR., LukanichJ.M., BaldiniE.H., MentzerS.J.: Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thoracic Cardiovasc Surg, 117: 54–63, 1999.
21.
VogelzangN.J.: Emerging insights into the biology and therapy of malignant mesothelioma. Semin Oncol, 29(suppl. 18): 35–42, 2002.
22.
VogelzangN.J., RusthovenJ.J., SymanowskiJ., DenhamC., KaukelE., RuffleP., GatzemeierU., BoyerM., EmriS., ManegoldC., NiyikizaC., PaolettiP.: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol, 21: 2636–2644, 2003.
23.
GercovichF.G., LunaM.A., GottliebJ.A.: Increased incidence of cerebral mestastases in sarcoma patients with prolonged survival from chemotherapy: report of cases of leiomyosarcoma and chondrosarcoma. Cancer, 36: 1843–1851, 1975.
24.
MarsaG.W., JohnsonR.E.: Altered pattern of metastasis following treatment of Ewing's sarcoma with radiotherapy and adjuvant chemotherapy. Cancer, 27: 1051–1054, 1971.
